The Chart of the Day is Nxstage Medicine (NXTM)
with both a Trend Spotter buy signal and 96% technical buy signals.
The Relative Strength Index of 79.94% was earned by having 18 new highs
and a gain of 27.72% in the last month. The stock was discovered on
the New High List.
The
company is a medical device company that develops, manufactures and
markets systems for the treatment of end-stage renal disease, or ESRD,
and acute kidney failure.
Please share this article
No comments:
Post a Comment